FDA Approved: CYCLOPHOSPHAMIDE — Supplemental Application (Civica, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Civica, Inc. to market a generic cyclophosphamide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Breast Cancer
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

SUPPL AP for CYCLOPHOSPHAMIDE (CYCLOPHOSPHAMIDE)